The Goals of Research During an Epidemic

American Journal of Bioethics

Volumn 15, Issue 4, 2015, Pages 47-50

  Rid, Annette ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); ETHICS; HEMORRHAGIC FEVER, EBOLA; HUMAN; HUMAN EXPERIMENT; METHODOLOGY; PROCEDURES;

CLINICAL TRIALS AS TOPIC; HEMORRHAGIC FEVER, EBOLA; HUMANS; RESEARCH DESIGN; THERAPEUTIC HUMAN EXPERIMENTATION;

EID: 84927616034     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2015.1009573     Document Type: Note

References (20)

1. Ansumana, R., K. H. Jacobsen, M. Idris, et al. 2014. Ebola in Freetown Area, Sierra Leone—A case study of 581 patients. New England Journal of Medicine 372(6): 587–588.
2. Abedamowo, C., O. Bah-Sow, F. Binka, et al. 2014. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 384: 1423–1424.
3. Bah, E. I., M. C. Lamah, T. Fletcher, et al. 2015. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. New England Journal of Medicine 372(1): 40–47.
4. Beeching, N. J., M. Fenech, and C. F. Houlihan. 2014. Ebola virus disease. British Medical Journal 349: g7348.
5. Caplan, A. L., C. Plunkett, and B. Levin. 2015. Selecting the right tool for the job. American Journal of Bioethics 15(4): 4–10.
6. Cox, E., L. Borio, and R. Temple. 2014. Evaluating Ebola therapies—The case for RCTs. New England Journal of Medicine 371(25): 2350–2351.
7. Folayan, M., B. Brown, A. Yakubu, et al. 2014. Compassionate use of experimental drugs in the Ebola outbreak. Lancet 384(9957): 1843.
8. Goodman, J. L. 2014. Studying “secret serums”—Toward safe, effective Ebola treatments. New England Journal of Medicine 371(12): 1086–1089.
9. Hay, M., D. W. Thomas, J. L. Craighead, et al. 2014. Clinical development success rates for investigational drugs. Nature Biotechnology 32: 40–51.
10. Joffe, S. 2014. Evaluating novel therapies during the Ebola epidemic. Journal of the American Medical Association 312(13): 1299–1300.
11. Kreuels, B., D. Wichman, P. Emmerich, et al. 2014. A case of severe Ebola virus infection complicated by gram-negative septicemia. New England Journal of Medicine 371(25): 2394–2401.
12. Lyon, G. M., A. K. Mehta, J. B. Varkey, et al. 2014. Clinical care of two patients with Ebola virus disease in the United States. New England Journal of Medicine 371(25): 2402–2409.
13. Parra, J. M., O. J. Salmerón, and M. Velasco. 2014. The first case of Ebola virus disease acquired outside Africa. New England Journal of Medicine 371(25): 2439–2440.
14. Piot, P. 2012. No time to lose: A life in pursuit of deadly viruses. New York, NY: W. W. Norton & Company.
15. Rid, A., and E. J. Emanuel. 2014. Ethical considerations of experimental interventions in the Ebola outbreak. Lancet 384(9957): 1896–1899.
16. Schieffelin, J. S., J. G. Shaffer, A. Goba, et al. 2014. Clinical illness and outcomes in patients with Ebola in Sierra Leone. New England Journal of Medicine 371(22): 2092–2100.
17. World Health Organization. 2014a. Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD), Summary of the panel discussion, August 12. Available at: who.int/tmediacentre/news/statements/2014/ebola-ethical-review-summary/en (accessed 14January2015).
18. World Health Organization. 2014b. WHO Meeting of the Scientific and Technical Advisory Committee on Ebola Experimental Interventions—Briefing note. Geneva, November 13. Available at: who.int/medicines/ebola-treatment/scientific_tech_meeting/en/#.VHOOGRkGy40.email (accessed 14 January2015).
19. World Health Organization Ebola Response Team. 2014. Ebola virus disease in west Africa—the first 9 months of the epidemic and forward projections. New England Journal of Medicine 371(16): 1481–1495.
20. World Health Organization Ebola Response Team. 2015. West African Ebola epidemic after one year—slowing but not yet under control. New England Journal of Medicine 372(6): 584–587.